Govindan R, Ihde D C
Division of Medical Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Chest Surg Clin N Am. 1997 Feb;7(1):167-81.
Small cell lung cancer (SCLC) accounts for 20% of all lung cancers. More than two thirds of patients with SCLC present with clinically evident distant metastases. Patients with limited stage disease are treated with a combination of chemotherapy and chest radiation. Patients with extensive stage disease and good performance status are candidates for combination chemotherapy. Almost all patients relapse after an initial response. This article focuses on the common sense approach to the management of SCLC.
小细胞肺癌（SCLC）占所有肺癌的20%。超过三分之二的小细胞肺癌患者出现临床明显的远处转移。局限期疾病患者采用化疗和胸部放疗联合治疗。广泛期疾病且身体状况良好的患者适合联合化疗。几乎所有患者在初始缓解后都会复发。本文重点介绍小细胞肺癌管理的常识性方法。
